McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
628.18
+7.04 (1.13%)
Nov 21, 2024, 1:49 PM EST - Market open
McKesson Revenue
McKesson had revenue of $93.65B in the quarter ending September 30, 2024, with 21.29% growth. This brings the company's revenue in the last twelve months to $330.19B, up 13.43% year-over-year. In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth.
Revenue (ttm)
$330.19B
Revenue Growth
+13.43%
P/S Ratio
0.25
Revenue / Employee
$6,474,255
Employees
51,000
Market Cap
79.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | 231.05B | 16.73B | 7.81% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 367.25B |
| Cencora | 293.96B |
| The Cigna Group | 229.75B |
| Elevance Health | 174.02B |
| HCA Healthcare | 69.62B |
| GSK | 41.97B |
| Takeda Pharmaceutical | 31.73B |
| Becton, Dickinson and Company | 19.83B |
MCK News
- 12 days ago - McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network - Seeking Alpha
- 14 days ago - These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings - Benzinga
- 14 days ago - McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - McKesson raises annual profit forecast on strength in its U.S. pharma segment - Reuters
- 14 days ago - McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 21 days ago - McKesson Corporation Declares Quarterly Dividend - Business Wire
- 6 weeks ago - McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff - Seeking Alpha
- 6 weeks ago - InspiroGene by McKesson Unveils First-of-its-Kind Report on State of the Cell and Gene Therapy Landscape, Revealing Unparalleled Optimism Amidst Complex Challenges - Business Wire